Home > Balance Sheet > AUROBINDO PHARMA

AUROBINDO PHARMA
Sundry Debtors

    Back to Balance Sheet
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Sundry Debtors History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Sundry Debtors ₹5,746 Cr₹4,817 Cr₹4,466 Cr₹4,012 Cr₹3,503 Cr

What is the latest Sundry Debtors ratio of AUROBINDO PHARMA ?

The latest Sundry Debtors ratio of AUROBINDO PHARMA is ₹5,746 Cr based on Mar2025 Consolidated results.
Year Sundry Debtors
Mar2025₹5,746 Cr
Mar2024₹4,817 Cr
Mar2023₹4,466 Cr
Mar2022₹4,012 Cr
Mar2021₹3,503 Cr

How is Sundry Debtors of AUROBINDO PHARMA Trending?

Years Sundry Debtors % Change
Mar2025 ₹5,746 Cr
19.29
Mar2024 ₹4,817 Cr
7.84
Mar2023 ₹4,466 Cr
11.32
Mar2022 ₹4,012 Cr
14.53
Mar2021 ₹3,503 Cr -

Compare Sundry Debtors of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹70,131.6 Cr -2.1% 11.3% -2.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹425,102.0 Cr -0.7% 4.3% 0.2% Stock Analytics
DIVIS LABORATORIES ₹170,299.0 Cr -0.6% -2.6% 6.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹126,753.0 Cr 0.4% 4.7% 19.8% Stock Analytics
CIPLA ₹121,735.0 Cr -1.3% -4.8% 2.6% Stock Analytics
DR REDDYS LABORATORIES ₹103,155.0 Cr -1.1% -3.7% 2.5% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-2.1%

11.3%

-2.1%

SENSEX

-0.1%

0%

9%


You may also like the below Video Courses